Cytokine-Induced Endothelial Cell Activation

Cytokine-induced endothelial cell activation is a central event in inflammation, cardiovascular disease and host defence. Pro-inflammatory cytokines such as tumour necrosis factor-α, interleukin-1β and lipopolysaccharide engage specific receptors on the endothelial surface, triggering intracellular signalling cascades including NF-κB, MAPK and JNK/p38 pathways. This leads to rapid transcriptional upregulation of adhesion molecules (E-selectin, VCAM-1, ICAM-1), secretion of chemokines and changes in cytoskeletal organisation that increase vascular permeability. Actin remodelling opens intercellular junctions, enabling leukocyte rolling, firm adhesion and transendothelial migration. Dysregulated activation contributes to atherogenesis, acute lung injury, sepsis and chronic inflammatory disorders. Understanding the molecular switches that balance protective immunity and vascular injury has underpinned the development of targeted inhibitors of key kinases, redox modulators and adhesion-blockade therapies, highlighting the global importance of controlling endothelial activation for human health.

Research from Nature Portfolio

Recent studies have elucidated the role of cytoskeletal regulators in cytokine-driven endothelial remodelling. Differential expression of EPLIN-α and EPLIN-β modulates TNF-α-induced actin dynamics to control intercellular gap formation and pore closure, thereby fine-tuning leukocyte transendothelial migration. This work integrates junctional mechanics alongside established adhesion-molecule upregulation to offer a more complete model of inflammatory diapedesis. Foundational research on the mitogen-activated protein kinase kinase kinase kinase MAP4K4 has identified it as a pivotal signalling node in endothelial inflammation and atherogenesis. Endothelial-specific deletion or pharmacological inhibition of MAP4K4 attenuates NF-κB activation, reduces adhesion-molecule expression and suppresses monocyte recruitment in experimental atherosclerosis, highlighting a promising target to restrain cytokine-driven vascular injury.

Cytokine-Induced Endothelial Cell Activation publication trend

The graph below shows the total number of articles in cytokine-induced endothelial cell activation across all publications each year (not limited to Nature Index journals).

Technical terms

Cytokine: A small secreted protein that mediates cell-to-cell communication during immune responses.

Endothelial cell activation: A state in which endothelial cells increase permeability, express adhesion molecules and secrete chemokines in response to inflammatory stimuli.

NF-κB: A transcription factor that controls expression of genes involved in inflammation and cell survival.

MAPK: Mitogen-activated protein kinase, a signalling module that regulates cellular responses to stress and cytokines.

E-selectin: An endothelial adhesion molecule induced by cytokines that mediates leukocyte rolling.

Transendothelial migration (TEM): The process by which leukocytes move across the endothelial barrier into tissues.

References

1. E-selectin in vascular pathophysiology. Frontiers in Immunology (2024).
2. A specific role for endothelial EPLIN-isoform-regulated actin dynamics in neutrophil transmigration. Scientific Reports (2025).
3. Endothelial protein kinase MAP4K4 promotes vascular inflammation and atherosclerosis. Nature Communications (2015).
4. Tumor Necrosis Factor ä-Induced E-selectin Expression Is Activated by the Nuclear Factor-κB and c-JUN N-terminal Kinase/p38 Mitogen-activated Protein Kinase Pathways*. Journal of Biological Chemistry (1997).
5. Cynarin attenuates LPS-induced endothelial inflammation via upregulation of the negative regulator MKP-3. Animal Cells and Systems (2022).